3 completed. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
Follow Sunovion Respiratory Development Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD SUN-101 50 mcg BID eFlow (CS) nebulizer, SUN-101 25 mcg BID eFlow (CS) nebulizer, Placebo BID eFlow Closed System (CS) nebulizer - COPD | Phase 3 | Completed | Sunovion Respiratory Development Inc. | 653 | 2015-02-01 | 2018-03-22 |
| Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4) SUN-101 50 mcg BID eFlow (CS) nebulizer, SUN-101 25 mcg BID eFlow (CS) nebulizer, Placebo eFlow (CS) nebulizer - COPD, Chronic Obstructive Pulmonary Disease | Phase 3 | Completed | Sunovion Respiratory Development Inc. | 641 | 2015-02-01 | 2018-03-13 |
| A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD SUN-101 50 mcg BID eFlow (CS) nebulizer, Spiriva® 18 mcg QD Handihaler - Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Completed | Sunovion Respiratory Development Inc. | 1087 | 2014-10-01 | 2018-03-13 |
Pulmonary Disease, Chronic Obstructive (3)
Nebulizers and Vaporizers (3) · Glycopyrrolate (1) · Tiotropium Bromide (1)
United States (3) · Czechia (1) · Hungary (1) · Russia (1)